An Esoteric View on Insurance and Risk

Monday Morning Reads

Good morning and welcome to another week, albeit an abbreviated one, and the second half of 2018. Here is what I am reading as we start July:

Family owned Recordati, an Italian Pharma Company, is being bought by CVC Capital Partners for almost $7B (Pitchbook).

The fee for an NDA has gone from $208,000 in 1995 to $2,421,495 in 2018. Drug companies now provide 75% of the FDA’s drug review budget so the question becomes does this create a bias at the FDA to approve drugs (Forbes).